Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting120%
unknown120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Lees Screen in Concomitant Strabismus

NCT04213053
completedphase_3

Botox Instead of Strabismus Surgery (BISS)

NCT03459092
completednot_applicable

Management of Consecutive Exotropia

NCT04961021
unknown

Choroidal and Retinal Thickness Following Strabismus Surgery

NCT04285177
completednot_applicable

Basic Intermittent Exotropia and Risk Factors for Postoperative Overcorrection and Under Correction

NCT03153423

Clinical Trials (5)

Showing 5 of 5 trials
NCT04213053Not Applicable

Lees Screen in Concomitant Strabismus

Recruiting
NCT03459092Phase 3

Botox Instead of Strabismus Surgery (BISS)

Completed
NCT04961021Not Applicable

Management of Consecutive Exotropia

Completed
NCT04285177

Choroidal and Retinal Thickness Following Strabismus Surgery

Unknown
NCT03153423Not Applicable

Basic Intermittent Exotropia and Risk Factors for Postoperative Overcorrection and Under Correction

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5